About

Peter Harley, PhD, is Head of Technology at Crux Product Design, leading a multidisciplinary team of experts in applied sciences, simulation, data analytics, machine learning and life sciences that operates across the drug delivery sector and is the sitting Chair of the NAFEMS Medical Device & Life Sciences simulation working group. Dr Harley has a background in the automotive and consumer electronics industries, where simulation is key to rapid development and de-risking, and therefore reduced time to market.
He now translates technologies into robust investment opportunities in the medical device and pharmaceutical spaces, aiming to deliver accurate digital twins via in silico approaches, develop forensic post-processing techniques and drive sustainable artificial intelligence modelling techniques.

Contributions

EXPERT VIEW

HOW CUTTING EDGE IN SILICO APPROACHES CAN REDUCE TIME AND RISK IN DEVELOPMENT OF INHALATION DEVICES

Dr Peter Harley, Mariam Al-Amari and Matt Jones explore how in silico approaches can transform pulmonary and nasal drug delivery device development, illustrating through case studies – spanning low-global-warming potential propellants, assembly robustness, device-user interaction, variability and capsule piercing dynamics – how simulation-led in silico approaches can improve understanding of device performance and identify risks early, reducing development costs and accelerating the path to more reliable, innovative and patient-friendly drug-device systems.